Your session is about to expire
← Back to Search
Behavioral Intervention
Electronic Handouts for Multiple Myeloma
N/A
Waitlist Available
Led By Rahul Banerjee, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
Study Summary
This trial will investigate whether digital life coaching can help reduce anxiety and insomnia in multiple myeloma patients undergoing stem cell transplants, by working with them longitudinally to accomplish personal goals.
Eligible Conditions
- Multiple Myeloma
- Bone Marrow Transplant
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Comparison of patients with >=1 benzodiazepine and Z-class (B/Z) prescriptions (versus < 1 B/Z prescriptions)
Estimate change in B/Z usage
Number of participants with a missing NCCN Distress Thermometer (DT) assessment
+2 moreSecondary outcome measures
Change in NCCN Distress Thermometer (DT) Scores
Change in PROMIS 4-item Sleep Disturbance Short Form (SF-4a) Scores
Change in PROMIS Global Health (GH) Scale Scores
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Pack Health's Digital Life Coaching (DLC)Experimental Treatment2 Interventions
Participants will receive 16 weeks of access to a trained human life coach employed by Pack Health. Coaches will communicate via phone calls, text messages, emails, and links to web-based Pack Health resources plus the addition of generic wellness-related electronic handouts at the time of each email reminder for participant-reported outcome (PRO) assessments
Group II: Quasi-usual care control armActive Control1 Intervention
Participants will receive usual supportive care for stem cell transplantation plus the addition of generic wellness-related electronic handouts at the time of each email reminder for participant-reported outcome (PRO) assessments
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pack Health's Digital Life Coaching (DLC)
2020
N/A
~60
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,495 Total Patients Enrolled
19 Trials studying Multiple Myeloma
1,140 Patients Enrolled for Multiple Myeloma
American Society of Clinical OncologyOTHER
33 Previous Clinical Trials
147,493 Total Patients Enrolled
2 Trials studying Multiple Myeloma
3,820 Patients Enrolled for Multiple Myeloma
Rahul Banerjee, MDPrincipal InvestigatorUniversity of California, San Francisco
4 Previous Clinical Trials
167 Total Patients Enrolled
4 Trials studying Multiple Myeloma
167 Patients Enrolled for Multiple Myeloma
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any unoccupied slots available to participants in this research?
"This particular trial is no longer recruiting, having first been posted on December 29th 2020 and last updated on July 12th 2022. However, 851 other studies are still seeking participants at this time."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger